TTOO - t2biosystems.com Operating income before deduction of amortization

Graphic logo of t2biosystems.com (TTOO)

Low penetration of sepsis diagnostic systems in clinics is constraining the operating leverage of T2 Biosystems, Inc. (TTOO), as clearly demonstrated by the EBITDA chart provided by the GURU.Markets service, which shows the current metric value at . The business growth of T2 Biosystems, Inc. (TTOO) is based on the FDA approval of new tests and the speed of sample analysis; meanwhile, the company's technologies support ESG goals by reducing excessive medication use and the volume of medical waste.

TTOO T2 Biosystems Inc Operating profit before deduction of amortization (07/04/2022 - 11/10/2026)

T2 Biosystems (TTOO) - metric breakdowns and financial figures

- current price and projected stock value:
Price T2 Biosystems Inc|TTOO - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization T2 Biosystems|TTOO - Enterprise Value
- balance sheet equity data:
Accounting Value per Share T2 Biosystems|TTOO - Company Net Assets|Market Value to Book Value t2biosystems.com|TTOO - Aggregate Company Assets
- business debt structure and liquidity details:
Total Debt to Equity Ratio T2 Biosystems, Inc.|TTOO - Long-Term Debt to Capital|Current Liabilities to Capital T2 Biosystems Inc.|TTOO - Company Aggregate Debts|Debt to Book Value Ratio T2 Biosystems|TTOO - Company Long-Term Debts|Short-Term Debt Volume T2 Biosystems|Quick Liquidity Indicator t2biosystems.com
- earnings and multiples data:
TTOO - Net Profit|Projected Future Earnings T2 Biosystems, Inc.|TTOO - Price to Earnings Ratio|Future Price to Earnings t2biosystems.com|TTOO - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation T2 Biosystems|TTOO - Operating profit EBITDA|Net earnings per one share for the last twelve months T2 Biosystems|TTOO - Earnings per share for the last twelve months|Net earnings per share growth for the trailing year t2biosystems.com|TTOO - Net earnings per share growth this year|Earnings growth forecast for next year T2 Biosystems, Inc.
Summary company analytics:T2 Biosystems Inc - TTOO
Mass-produced product of T2 Biosystems, Inc.

In-house quality control at its Massachusetts facilities ensures T2 Biosystems, Inc. (TTOO) maintains shipment stability, which directly impacts the dynamics of EBITDA. This indicator isolates net cash flow from the influence of debt burdens and fiscal factors, allowing investors to assess the real efficiency of business scaling and recognize stagnation in fundamental growth in a timely manner.

Who T2 Biosystems, Inc. competes with

Company profit before taxes, interest and amortization ABT (Abbott Corp.)|Thermo Fisher Scientific - Operating profit EBITDA|Operating income before deduction of amortization gehealthcare.com GEHC|MTD: Operating profit EBITDA|Operating profit before deduction of amortization Waters Corp|Operating profit before deduction of amortization TECH|BRKR: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Azenta, Inc. (AZTA)|Operating profit before deduction of amortization vareximaging.com VREX|Operating profit EBITDA SMLR (Semler Scientific)|Butterfly Network Inc (BFLY) - Profit before interest, taxes and amortization|Mesa Labs Corp - Operating profit EBITDA|QSI (Quantum-Si Corporation) - Operating profit before amortization|NNOX: Operating profit EBITDA|QTRX - Operating income before deduction of amortization|MASS (908 Devices) - Operating profit EBITDA|Operating profit before deduction of amortization CapsoVision Medical (CV)|Operating profit EBITDA MXCT|Operating profit EBITDA rapidmicrobio.com (RPID)|Profit before payment of interest, taxes and amortization Seer, Inc. SEER|hyperfine.io - Profit before payment of interest, taxes and amortization|FONR: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization DXR (Daxor Corporation)|MDAI: Operating profit EBITDA|Profit before interest, taxes and amortization Organovo Holdings Inc. (VIVS)|Profit before payment of interest, taxes and amortization Aclarion|AKYA - Operating profit before depreciation charges|Operating profit before deduction of amortization THMO (ThermoGenesis Holdings)|Operating profit EBITDA talis.bio (TLIS)